Primary Record
vinpocetine
- In stock
- 7,263 g
- Purity
- 99.8 %
- CAS
- 42971-09-5
Compound Identifiers & Properties
- CAS
- 42971-09-5
- PubChem CID
- 443955
- SMILES
- CC[C@@]12CCCN3[C@@H]1C4=C(CC3)C5=CC=CC=C5N4C(=C2)C(=O)OCC
- Canonical SMILES
- CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c(n1c1ccccc41)[C@@H]32
Names & Synonyms
- vinpocetine
- Cavinton
- Ceractin
- Bravinton
- 42971-09-5
- Vinporal
- Vinpocetinum
- Ultra-Vinca
- Ethyl apovincaminate
- Vinpocetina
- Ethyl apovincamin-22-oate
- Apovincaminic acid ethyl ester
- Vinpocetin
- Kavinton
- Vinpo
- TCV-3B
- Vinpocetine 20mg
- Vinpocetine CRS
- Ethyl apovincamin
- Ethyl (+)-apovincaminate
- Apovincaminate d'ethyle
- TCV 3B
- Intelectol (TN)
- Ethyl (+)-cis-apovincaminate
- Cavinton (TN)
- Vinpocetinum [INN-Latin]
- Prestwick_963
- (+)-cis-Cavinton
- RGH 4405
- cis-Apovincaminic acid ethyl ester
- Vinpocetine (Cavinton)
- Vinpocetine (Standard)
- RGH-4405
- Spectrum_001400
- (+)-Apovincaminic acid ethyl ester
- Ethyl cis-apovincaminate
- SpecPlus_000327
- AC1L9FGV
- Apovincaminate d'ethyle [French]
- VINPOCETINE [MI]
- Opera_ID_1325
- Prestwick0_000268
- Prestwick1_000268
- Prestwick2_000268
- Prestwick3_000268
- RefChem:901876
- Spectrum2_001529
- Spectrum3_000961
- Spectrum4_001075
- Spectrum5_000966
- Vinpocetine [USAN:INN:JAN]
- VINPOCETINE [DSC]
- VINPOCETINE [INN]
- VINPOCETINE [JAN]
- C22H26N2O2
- DTXSID5023740
- VINPOCETINE [USAN]
- CHEMBL71752
- D06BCB
- VINPOCETINE 100MG
- UNII-543512OBTC
- VINPOCETINE [VANDF]
- MLS000069635
- Vinpocetine (JAN/USAN/INN)
- DTXCID903740
- ethyl apovincaminate tartrate
- Vinpocetine-ethyl apovincaminate
- 543512OBTC
- Ethyl(+)-cis-apovincaminate
- VINPOCETINE [MART.]
- (+)-cis-Apovincaminic acid ethyl ester
- Lopac0_001257
- MFCD00211233
- SCHEMBL50081
- BSPBio_000116
- BSPBio_002561
- KBioGR_001430
- KBioSS_001880
- VINPOCETINE [USP-RS]
- VINPOCETINE [WHO-DD]
- MLS001076294
- ARONIS24464
- DivK1c_006423
- NSC-760093
- SPECTRUM1503115
- V6383_SIGMA
- Vinpocetine, >=98%, solid
- EINECS 256-028-0
- Ethyl eburnamenine-14-carboxylate
- SPBio_001318
- SPBio_002335
- DDNCQMVWWZOMLN-IRLDBZIGSA-N
- AY 27,255
- BPBio1_000128
- cid_443955
- GTPL5285
- TCV-38
- Vinpocetin - Bio-X trade mark
- Vinpocetine, analytical standard
- REGID_for_CID_443955
- SCHEMBL29364972
- Vinpocetine [USAN:INN:BAN:JAN]
- CHEBI:32297
- ERK5-2J18
- ethyl apovincaminate, 3H-labeled
- KBio1_001367
- KBio2_001880
- KBio2_004448
- KBio2_007016
- KBio3_001781
- AY-27,255
- BRN 0900803
- DTXSID10904848
- N06BX18
- DDNCQMVWWZOMLN-RBBKRZOGSA-N
- AY-27255
- GLXC-07972
- HMS1568F18
- HMS1922G05
- HMS2090J22
- HMS2092L06
- HMS2095F18
- HMS3263L16
- HMS3402D12
- HMS3411H11
- HMS3675H11
- HMS3712F18
- HMS3887E17
- Pharmakon1600-01503115
- VINPOCETINE [EP MONOGRAPH]
- 3-alpha,16-alpha-Apovincaminic acid ethyl ester
- ethyl apovincaminate, (+-)-isomer
- AMY39087
- BCP04123
- MSK11212
- Tox21_110648
- Tox21_110839
- Tox21_501257
- BDBM50059033
- CCG-39307
- CID443955
- Eburnamenine-14-carboxylic acid ethyl ester
- ethyl apovincaminate tartrate (1:1)
- HY-13295R
- NCGC00018204-09
- NSC760093
- PD-185
- s2110
- ZINC19796031
- AY 27255
- SMR000058241
- AKOS015896480
- C22-H26-N2-O2
- Tox21_110648_1
- 3A,16A-Apovincaminic acid ethyl ester
- ACN-036654
- CID:443955
- CS-0545
- CS-O-02572
- DB12131
- EBC-574228
- Eburnamenine-14-carboxylic acid, ethyl ester, (3a,16a)-
- ethyl apovincaminate, (3alpha,16alpha)-isomer
- FV11741
- J3.510F
- LP01257
- NSC 760093
- RP18037
- SDCCGSBI-0051224.P003
- Vinpocetine 1.0 mg/ml in Acetonitrile
- ethyl apovincaminate, (16alpha)-isomer
- (3S,16S)-apovincaminic acid ethylester
- NCGC00016854-03
- NCGC00018204-05
- NCGC00018204-06
- NCGC00018204-07
- NCGC00018204-08
- NCGC00018204-10
- NCGC00018204-11
- NCGC00018204-13
- NCGC00021727-04
- NCGC00021727-05
- NCGC00021727-06
- NCGC00021727-07
- NCGC00168782-01
- NCGC00261942-01
- NCGC00263865-01
- NCGC00263865-04
- AC-22612
- AS-13868
- BV164528
- HY-13295
- LS-63711
- SC-18612
- SID:53790458
- ST056350
- V 6383
- AB2000514
- CAS-42971-09-5
- Eburnamenine-14-carboxylic acid ethyl ester;
- EU-0101257
- FT-0630629
- FT-0776311
- NS00006850
- V0115
- A12521
- D01371
- Eburnamenine-14-carboxylic acid, ethyl ester, (3alpha,16alpha)-
- ethyl (3alpha,16alpha)-eburnamenine-14-carboxylate
- J10479
- M02659
- W-5089
- AB00052317_02
- ethyl apovincaminate, 2-oxopentanedioate (1:1)
- 971V095
- A846459
- AO-645/21219012
- C013983
- Ethyl 3alpha,16alpha-eburnamenine-14-carboxylate
- Q420288
- SR-01000000118
- SR-01000075633
- (3|A,16|A)-Eburnamenine-14-carboxylic acid ethyl ester
- (41S,13aS)-ethyl 13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
- I06-1883
- SR-01000000118-3
- SR-01000075633-1
- SR-01000075633-3
- SR-01000075633-4
- BRD-K53318339-001-05-8
- BRD-K53318339-001-23-1
- BRD-K53318339-001-24-9
- (3?,16?)-Eburnamenine-14-carboxylic acid ethyl ester
- (3alpha, 16alpha)-Eburnamenine-14-carboxylic acid ethyl ester
- (3alpha,16alpha)-Eburnamenine-14-carboxylic acid ethyl
- (3S,16S)-Eburnamenine-14-carboxylic acid ethyl ester
- ethyl (15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene-17-carboxylate
- B0046-464044
- eburnamenine-14-carboxylic acid, ethyl ester, (3 alpha,16 alpha)-
- Eburnamenine-14-carboxylic acid, ethyl ester, (3-alpha,16-alpha)-
- Vinpocetine Working Standard (Secondary Reference Standard)
- Vinpocetine, European Pharmacopoeia (EP) Reference Standard
- (3alpha,16alpha)-Eburnamenine-14-carboxylic acid ethyl ester
- ethyl (41S,13aS)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
- (3-alpha,16-alpha)-Eburnamenine-14-carboxylic acid ethyl ester
- Vinpocetine, 98%, a selective inhibitor for PDE1 - 100mg 100mg
- Vinpocetine, United States Pharmacopeia (USP) Reference Standard
- 1H-Indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine, eburnamenine-14-carboxylic acid deriv.
- 80038-06-8
- EBURNAMENINE 14-CARBOXYLIC ACID ETHYL ESTER (3.ALPHA.,16.ALPHA.)
- Eburnamenine-14-carboxylic acid, ethyl ester, (3.alpha.,16.alpha.)-
- ethyl (15s,19s)-15-ethyl-1,11-diazapentacyclo[9.6.2.0^{2,7}.0^{8,18}.0^{15,19}]nonadeca-2(7),3,5,8(18),16-pentaene-17-carboxylate
- (11aS,11bS)-11a-Ethyl-2,3,4,5,11a,11b-hexahydro-1H-3a,9b-diaza-benzo[cd]fluoranthene-10-carboxylic acid ethyl ester
- (13aS)-13abeta-Ethyl-2,3,5,6,13a,13bbeta-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylic acid ethyl ester
- (3aS,11bS)-3a-ethyl-1,2,3,3a,10,11b-hexahydro-11H-5a,11a-diaza-benzo[cd]fluoranthene-5-carboxylic acid ethyl ester
- (41S,13aS)-Ethyl 13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-ij]pyrido[3,2,1-de][1,5]naphthyridine-12-carboxylate
- (41S,13aS)-ethyl13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
- 115986-87-3
- 11a-Ethyl-2,3,4,5,11a,11b-hexahydro-1H-3a,9b-diaza-benzo[cd]fluoranthene-10-carboxylic acid 2-nitrooxy-ethyl ester(Vinpocetine)
- 256-028-0
- 42971-12-0
- 68780-77-8
- ethyl (15S,19S)-15-ethyl-1,11-diazapentacyclo(9.6.2.0^(2,7).0^(8,18).0^(15,19))nonadeca-2,4,6,8(18),16-pentaene-17-carboxylate
- ethyl (15S,19S)-15-ethyl-1,11-diazapentacyclo(9.6.2.02,?.0?,1?.01?,1?)nonadeca-2,4,6,8(18),16-pentaene-17-carboxylate
- ethyl (15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.0^{2,7}.0^{8,18}.0^{15,19}]nonadeca-2,4,6,8(18),16-pentaene-17-carboxylate
- ethyl(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene-17-carboxylate
- Vinpocetine; Ethyl (13aS,13bS)-13a-ethyl-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate; 1H-Indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine eburnamenine-14-carboxylic acid deriv.; (+)-Apovincaminic acid ethyl ester; (+)-cis-Apovincaminic acid ethyl ester; AY 27255; Apovincaminic acid ethyl ester; Bravinton; Cavinton; Ceractin; Ethyl (+)-apovincaminate; Ethyl (+)-cis-apovincaminate; Ethyl apovincaminate; RGH 4405; TCV 3B; Ultra-Vinca; cis-Apovincaminic acid ethyl ester; (3alpha,16alpha)-Eburnamenine-14-carboxylic acid ethyl ester